trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion

Biochimie. 2010 Dec;92(12):1766-71. doi: 10.1016/j.biochi.2010.07.018. Epub 2010 Aug 13.

Abstract

Txnip (thioredoxin-interacting protein) is a protein with multifunctional roles in cellular responses and stress-related diseases. Txnip is involved in intracellular redox regulation and has been recently described as a possible link between redox state and metabolism. trans-Resveratrol (T-res) is a natural phytoalexin with antiproliferative, antiapoptotic and antioxidative effects. However, to date there have been no reports of the implication of Txnip in a model of liver acute stress such as ischemia-reperfusion (I/R) and no work has looked for a T-res effect on Txnip. Here we studied the effects of a post-ischemic treatment of T-res on the liver thioredoxin (Trx)/Txnip system and investigated whether the T-res effects were dependent on *NO production. In this work, liver I/R induced hepatic Txnip expression and T-res inhibited I/R Txnip expression. This decrease in Txnip expression by T-res was associated with an increase in liver Trx redox activity and a decrease in hepatic I/R-induced Trx-1 expression with no effect on Trx-2, on plasma Trx redox activity or on liver and plasma Trx reductase activity, independently of *NO production. In conclusion, these results show that in our model, not only did T-res protect Trx redox activity by diminishing the Txnip protein expression; it also reduced secretion of Trx1. This is the first report of a major implication of the Trx1/Txnip system in hepatic I/R injuries. It also affirms the importance of the antioxidant effect of T-res on the Trx1/Txnip system.

MeSH terms

  • Amidohydrolases / metabolism
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology
  • Blotting, Western
  • Carrier Proteins / blood
  • Carrier Proteins / metabolism*
  • Cell Cycle Proteins
  • Down-Regulation
  • Injections, Intravenous
  • Liver / blood supply
  • Liver / drug effects*
  • Liver / metabolism
  • Male
  • Nitric Oxide / blood
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Oxidation-Reduction / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / blood
  • Reperfusion Injury / metabolism*
  • Resveratrol
  • Stilbenes / administration & dosage
  • Stilbenes / pharmacology*
  • Thioredoxin-Disulfide Reductase / blood
  • Thioredoxin-Disulfide Reductase / metabolism
  • Thioredoxins / blood
  • Thioredoxins / metabolism

Substances

  • Antioxidants
  • Carrier Proteins
  • Cell Cycle Proteins
  • Stilbenes
  • TXNIP protein, rat
  • Nitric Oxide
  • Thioredoxins
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos2 protein, rat
  • Nos3 protein, rat
  • Thioredoxin-Disulfide Reductase
  • Amidohydrolases
  • dimethylargininase
  • Resveratrol